Related references
Note: Only part of the references are listed.Pancreatic Cancer Resistance to Treatment: The Role of Microbiota
Enrico Celestino Nista et al.
BIOMEDICINES (2023)
STNM01, the RNA oligonucleotide targeting carbohydrate sulfotransferase 15, as second-line therapy for chemotherapy-refractory patients with unresectable pancreatic cancer: An open label, phase I/IIa trial
Toshio Fujisawa et al.
ECLINICALMEDICINE (2023)
Cancer statistics, 2023
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2023)
Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial
Eva Versteijne et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
First data for sotorasib in patients with pancreatic cancer with KRAS p.G12C mutation: A phase I/II study evaluating efficacy and safety
John H Strickler et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Improving Palliative Care and Quality of Life in Pancreatic Cancer Patients
Vincent Chung et al.
JOURNAL OF PALLIATIVE MEDICINE (2022)
A meta-analysis evaluating the role of high-intensity focused ultrasound (HIFU) as a fourth treatment modality for patients with locally advanced pancreatic cancer
Maria P. Fergadi et al.
ABDOMINAL RADIOLOGY (2022)
BRCA 1/2 Germline Mutation Predicts the Treatment Response of FOLFIRINOX with Pancreatic Ductal Adenocarcinoma in Korean Patients
Ji Hoon Park et al.
CANCERS (2022)
Precision Medicine for BRCA/PALB2-Mutated Pancreatic Cancer and Emerging Strategies to Improve Therapeutic Responses to PARP Inhibition
Daniel R. Principe
CANCERS (2022)
Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment
Laura D. Wood et al.
GASTROENTEROLOGY (2022)
Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients
Bruna Dalmasso et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer
Rom Leidner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Venous resection for pancreatic cancer, a safe and feasible option? A review and meta
E. S. Zwart et al.
PANCREATOLOGY (2022)
Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer
J. H. Strickler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
KRYSTAL-1: Activity and safety of adagrasib (MRTX849) in patients with advanced/metastatic non–small cell lung cancer (NSCLC) harboring a KRASG12C mutation.
Alexander I. Spira et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Thermal ablation in pancreatic cancer: A scoping review of clinical studies
William Farmer et al.
FRONTIERS IN ONCOLOGY (2022)
Prognostic value of KRAS subtype in patients with PDAC undergoing radical resection
Manxiong Dai et al.
FRONTIERS IN ONCOLOGY (2022)
Simultaneous Gemcitabine and Percutaneous CT-Guided Irreversible Electroporation for Locally Advanced Pancreatic Cancer
Yangyang Ma et al.
JOURNAL OF ONCOLOGY (2022)
Cytotoxic Chemotherapy in Advanced Pancreatic Cancer
Muneeb Rehman et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2022)
Benefitial role of electrochemotherapy in locally advanced pancreatic cancer-radiological perspective
Oliwia Kozak et al.
POLISH JOURNAL OF RADIOLOGY (2022)
Surgical Outcomes After Total Pancreatectomy: A High-Volume Center Experience
Thomas F. Stoop et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Total Neoadjuvant Therapy for Operable Pancreatic Cancer
Rebecca Y. Kim et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Recurrence patterns and postrecurrence survival after curative intent resection for pancreatic ductal adenocarcinoma
Hordur Kolbeinsson et al.
SURGERY (2021)
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection
Johannes F. Fahrmann et al.
GASTROENTEROLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells
Yibo Fu et al.
CELLS (2021)
Irreversible Electroporation (IRE) Combined With Chemotherapy Increases Survival in Locally Advanced Pancreatic Cancer (LAPC)
Dimitrios Oikonomou et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2021)
Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial
M. S. Walma et al.
TRIALS (2021)
Endoscopic ultrasonography-guided celiac plexus neurolysis in patients with unresectable pancreatic cancer: An update
Guillermo Perez-Aguado et al.
WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY (2021)
Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins
Sophie Liot et al.
FRONTIERS IN IMMUNOLOGY (2021)
Irreversible Electroporation (IRE) in Locally Advanced Pancreatic Cancer: A Review of Current Clinical Outcomes, Mechanism of Action and Opportunities for Synergistic Therapy
Zainab L. Rai et al.
JOURNAL OF CLINICAL MEDICINE (2021)
The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies
Marwa Elsayed et al.
BIOMEDICINES (2021)
Pancreatic Cancer: A Review
Wungki Park et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial
Laetitia Dahan et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Open radiofrequency ablation as upfront treatment for locally advanced pancreatic cancer: Requiem from a randomized controlled trial
Isabella Frigerio et al.
PANCREATOLOGY (2021)
New therapeutic strategy: Personalization of pancreatic cancer treatment-irreversible electroporation (IRE), electrochemotherapy (ECT) and calcium electroporation (CaEP) - A pilot preclinical study
Julia Rudno-Rudzinska et al.
SURGICAL ONCOLOGY-OXFORD (2021)
Pancreatic cancer in 2021: What you need to know to win
Valeria Tonini et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better
Patrick Michl et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2021)
Diet and Exercise Interventions in Patients With Pancreatic Cancer A Scoping Review
Popi Kasvis et al.
PANCREAS (2021)
Technical advances in surgery for pancreatic cancer
M. Schneider et al.
BRITISH JOURNAL OF SURGERY (2021)
Robotic versus laparoscopic distal pancreatectomy: multicentre analysis
S. Lof et al.
BRITISH JOURNAL OF SURGERY (2021)
Pancreatic Adenocarcinoma, Version 2.2021
Margaret A. Tempero et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer
Shalini Moningi et al.
ADVANCES IN RADIATION ONCOLOGY (2021)
The role of seed implantation in patients with unresectable pancreatic carcinoma after relief of obstructive jaundice using ERCP
Wen Li et al.
BRACHYTHERAPY (2020)
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer
Roberto Petrioli et al.
JOURNAL OF GERIATRIC ONCOLOGY (2020)
Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation
Max M. Wattenberg et al.
BRITISH JOURNAL OF CANCER (2020)
A review on the efficacy and safety of iodine-125 seed implantation in unresectable pancreatic cancers
Sheng-Nan Jia et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2020)
Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation
Eileen M. O'Reilly et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
Eva Versteijne et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Application of Irreversible Electroporation Ablation as Adjunctive Treatment for Margin Enhancement: Safety and Efficacy
Erika Simmerman et al.
JOURNAL OF SURGICAL RESEARCH (2020)
Irreversible electroporation after induction chemotherapy versus chemotherapy alone for patients with locally advanced pancreatic cancer: A propensity score matching analysis
Chaobin He et al.
PANCREATOLOGY (2020)
Superior mesenteric artery first approach can improve the clinical outcomes of pancreaticoduodenectomy: A meta-analysis
Xiangyan Jiang et al.
INTERNATIONAL JOURNAL OF SURGERY (2020)
New Treatment Strategies for Metastatic Pancreatic Ductal Adenocarcinoma
Ritu Raj Singh et al.
DRUGS (2020)
AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review
Harry R. Aslanian et al.
GASTROENTEROLOGY (2020)
Predictable modulation of cancer treatment outcomes by the gut microbiota
Yoshitaro Heshiki et al.
MICROBIOME (2020)
International consensus guidelines on surveillance for pancreatic cancer in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club
William Greenhalf et al.
PANCREATOLOGY (2020)
Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer
Michelle McMullen et al.
CANCERS (2020)
Value of CT-Guided Percutaneous Irreversible Electroporation Added to FOLFIRINOX Chemotherapy in Locally Advanced Pancreatic Cancer: A Post Hoc Comparison
Eran van Veldhuisen et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2020)
Fifty Years of Surgery for Pancreatic Cancer
Thilo Hackert et al.
PANCREAS (2020)
The Pancreatic Microbiome is Associated with Carcinogenesis and Worse Prognosis in Males and Smokers
Jaideep Chakladar et al.
CANCERS (2020)
PARP Inhibition Increases the Reliance on ATR/CHK1 Checkpoint Signaling Leading to Synthetic Lethality-An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness
Patrycja Gralewska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Bratislava Statement: consensus recommendations for improving pancreatic cancer care
Joan Prades et al.
ESMO OPEN (2020)
An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine plus /- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocol
Manoop S. Bhutani et al.
ENDOSCOPIC ULTRASOUND (2020)
Systematic Review of Surgical and Percutaneous Irreversible Electroporation in the Treatment of Locally Advanced Pancreatic Cancer
Dimitrios Moris et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Avenger 500, a phase III open-label randomized trial of the combination of CPI-613 with modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreas.
Philip Agop Philip et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
The need for improvement in the management of fatigue, depression and pain in pancreatic cancer.
Amy Westermann et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Advanced Pancreatic Cancer: High-Intensity Focused Ultrasound (HIFU) and Other Local Ablative Therapies
Milka Marinova et al.
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN (2019)
Nonsteroidal anti-inflammatory drugs and pain in cancer patients: a systematic review and reappraisal of the evidence
D. J. Magee et al.
BRITISH JOURNAL OF ANAESTHESIA (2019)
The Effect of Nutrition Intervention with Oral Nutritional Supplements on Pancreatic and Bile Duct Cancer Patients Undergoing Chemotherapy
Seong Hyeon Kim et al.
NUTRIENTS (2019)
Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer
B. Lee et al.
ANNALS OF ONCOLOGY (2019)
Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA
Jee-Soo Lee et al.
MOLECULAR ONCOLOGY (2019)
Locally Advanced Pancreatic Cancer: Work-Up, Staging, and Local Intervention Strategies
Eran van Veldhuisen et al.
CANCERS (2019)
Comparison of overall survival and perioperative outcomes of laparoscopic pancreaticoduodenectomy and open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a systematic review and meta-analysis
Yu-Li Jiang et al.
BMC CANCER (2019)
Is total laparoscopic pancreaticoduodenectomy superior to open procedure? A meta-analysis
Hua Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Minimally Invasive Versus Open Distal Pancreatectomy (LEOPARD) A Multicenter Patient-blinded Randomized Controlled Trial
Thijs de Rooij et al.
ANNALS OF SURGERY (2019)
Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA)
Jony van Hilst et al.
ANNALS OF SURGERY (2019)
Optimizing the outcomes of pancreatic cancer surgery
Oliver Strobel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines
M. Fallon et al.
ANNALS OF ONCOLOGY (2018)
Effects of EUS-guided intratumoral injection of oligonucleotide STNM01 on tumor growth, histology, and overall survival in patients with unresectable pancreatic cancer
Makoto Nishimura et al.
GASTROINTESTINAL ENDOSCOPY (2018)
Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives
E. Molina-Montes et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2018)
Expert consensus statement on computed tomography-guided 125I radioactive seeds permanent interstitial brachytherapy
Junjie Wang et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)
Therapeutic developments in pancreatic cancer: current and future perspectives
John P. Neoptolemos et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017
Shuji Isaji et al.
PANCREATOLOGY (2018)
Radiofrequency assisted pancreaticoduodenectomy for palliative surgical resection of locally advanced pancreatic adenocarcinoma
Jayant Kumar et al.
Oncotarget (2018)
R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic Cancer
Ihsan Ekin Demir et al.
ANNALS OF SURGERY (2018)
Comparison of Perioperative Outcomes Between Laparoscopic and Open Approach for Pancreatoduodenectomy The PADULAP Randomized Controlled Trial
Ignasi Poves et al.
ANNALS OF SURGERY (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
Andrew McGuigan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Chinese expert consensus on radioactive 125I seeds interstitial implantation brachytherapy for pancreatic cancer
Baodong Gai et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)
A Systematic Review and Meta-analysis of Intraluminal Brachytherapy Versus Stent Alone in the Treatment of Malignant Obstructive Jaundice
Xinjian Xu et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2018)
Evidence on the analgesic role of bisphosphonates and denosumab in the treatment of pain due to bone metastases: A systematic review within the European Association for Palliative Care guidelines project
Josep Porta-Sales et al.
PALLIATIVE MEDICINE (2017)
Systematic review and meta-analysis of robotic versus open pancreaticoduodenectomy
Long Peng et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2017)
Laparoscopic versus open pancreaticoduodenectomy for pancreatic adenocarcinoma: long-term results at a single institution
John A. Stauffer et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2017)
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer
N. Boku et al.
EUROPEAN JOURNAL OF CANCER (2017)
EUS-guided fine-needle injection of gemcitabine for locally advanced and metastatic pancreatic cancer
Michael J. Levy et al.
GASTROINTESTINAL ENDOSCOPY (2017)
Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Alok A. Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The side effects and complications of percutaneous iodine-125 seeds implantation under CT-guide for patients with advanced pancreatic cancer
Wei-Fu Lv et al.
MEDICINE (2017)
Coupling of Homologous Recombination and the Checkpoint by ATR
Remi Buisson et al.
MOLECULAR CELL (2017)
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients
Alessandro Giardino et al.
PANCREATOLOGY (2017)
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Leore T. Geller et al.
SCIENCE (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Pancreatic Exocrine Insufficiency in Pancreatic Cancer
Miroslav Vujasinovic et al.
NUTRIENTS (2017)
An endoscopic ultrasonography-guided interstitial brachytherapy based special treatment-planning system for unresectable pancreatic cancer
Xiaotian Sun et al.
ONCOTARGET (2017)
Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline
Stephen Lutz et al.
PRACTICAL RADIATION ONCOLOGY (2017)
Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study
B. Schultheis et al.
ANNALS OF ONCOLOGY (2017)
Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification
J. W. Gilbert et al.
ANNALS OF ONCOLOGY (2017)
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
TaChung Yu et al.
CELL (2017)
Pancreatic Cancer Surgery The New R-status Counts
Oliver Strobel et al.
ANNALS OF SURGERY (2017)
A Multi-institutional Comparison of Perioperative Outcomes of Robotic and Open Pancreaticoduodenectomy
Amer H. Zureikat et al.
ANNALS OF SURGERY (2016)
Locally Advanced Pancreatic Cancer Neoadjuvant Therapy With Folfirinox Results in Resectability in 60% of the Patients
Thilo Hackert et al.
ANNALS OF SURGERY (2016)
Robotic versus laparoscopic distal pancreatectomy - The first meta-analysis
Paschalis Gavriilidis et al.
HPB (2016)
Role of local ablative techniques (Radiofrequency ablation and Irreversible Electroporation) in the treatment of pancreatic cancer
Salvatore Paiella et al.
UPDATES IN SURGERY (2016)
Mismatch repair status may predict response to adjuvant chemotherapy in resectable pancreatic ductal adenocarcinoma
Maziar Riazy et al.
MODERN PATHOLOGY (2015)
Population Attributable Risk for Pancreatic Cancer in Northern Italy
Valentina Rosato et al.
PANCREAS (2015)
Preoperative ultrasound ablation for borderline resectable pancreatic cancer: A report of 30 cases
Guojing Wang et al.
ULTRASONICS SONOCHEMISTRY (2015)
Symptoms of Pancreatic Cancer in Primary Care
Mia Schmidt-Hansen et al.
PANCREAS (2015)
Risk factors for pancreatic cancer: a summary review of meta-analytical studies
Patrick Maisonneuve et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)
A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments
Kareem N. Mohni et al.
PLOS ONE (2015)
Total Laparoscopic Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma Oncologic Advantages Over Open Approaches?
Kristopher P. Croome et al.
ANNALS OF SURGERY (2014)
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
T. Golan et al.
BRITISH JOURNAL OF CANCER (2014)
Nucleoside-catabolizing Enzymes in Mycoplasma-infected Tumor Cell Cultures Compromise the Cytostatic Activity of the Anticancer Drug Gemcitabine
Johan Vande Voorde et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Pancreatic Ductal Adenocarcinoma Radiology Reporting Template: Consensus Statement of the Society of Abdominal Radiology and the American Pancreatic Association
Mahmoud M. Al-Hawary et al.
RADIOLOGY (2014)
Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: A consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)
Johanna A. M. G. Tol et al.
SURGERY (2014)
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer
Ching-Wei D. Tzeng et al.
HPB (2014)
Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design
Matthew H. G. Katz et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Robotic versus Open Pancreatectomy: A Systematic Review and Meta-analysis
Jie Zhang et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival
Faruk Tas et al.
MOLECULAR AND CLINICAL ONCOLOGY (2013)
Neoadjuvant Therapy Is Associated With Improved Survival in Resectable Pancreatic Adenocarcinoma
Avo Artinyan et al.
CANCER (2011)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Psychological distress in patients with pancreatic cancer-an understudied group
Karen L. Clark et al.
PSYCHO-ONCOLOGY (2010)
Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
Sonja Gillen et al.
PLOS MEDICINE (2010)
Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma
Matthew H. G. Katz et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Safety and Efficacy of Percutaneous Fiducial Marker Implantation for Image-guided Radiation Therapy
Nishita Kothary et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2009)
The cytostatic activity of pyrimidine nucleosides is strongly modulated by Mycoplasma hyorhinis infection:: Implications for cancer therapy
Annelies Bronckaers et al.
BIOCHEMICAL PHARMACOLOGY (2008)
EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies
Aline Charabaty Pishvaian et al.
GASTROINTESTINAL ENDOSCOPY (2006)
Borderline resectable pancreatic cancer: Definitions, management, and role of preoperative therapy
Gauri R. Varadhachary et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Robotic resection of pancreatic neuroendocrine tumor
WS Melvin et al.
JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES-PART A (2003)
Hospital volume and surgical mortality in the United States.
JD Birkmeyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)